| Zacks Company Profile for Boston Scientific Corporation (BSX : NYSE) |
|
|
| |
| • Company Description |
| Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities.
Number of Employees: 53,000 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $102.41 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 6,948,153 shares |
| Shares Outstanding: 1,479.45 (millions) |
| Market Capitalization: $151,510.11 (millions) |
| Beta: 0.68 |
| 52 Week High: $107.53 |
| 52 Week Low: $71.88 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
3.09% |
0.00% |
| 12 Week |
8.68% |
-5.79% |
| Year To Date |
14.65% |
8.32% |
|
|
|
|
| |
|
|
| |
| • General Corporate Information |
Officers
Michael F. Mahoney - Chief Executive Officer;Chairman of the Board;Pres
Daniel J. Brennan - Executive Vice President and Chief Financial Offic
Emily M. Woodworth - Senior Vice President; Global Controller and Chief
Charles J. Dockendorff - Director
Yoshiaki Fujimori - Director
|
|
Peer Information
Boston Scientific Corporation (BJCT)
Boston Scientific Corporation (CADMQ)
Boston Scientific Corporation (APNO)
Boston Scientific Corporation (UPDC)
Boston Scientific Corporation (IMTIQ)
Boston Scientific Corporation (CYGN)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 101137107
SIC: 3841
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 07/23/25
|
|
Share - Related Items
Shares Outstanding: 1,479.45
Most Recent Split Date: 11.00 (2.00:1)
Beta: 0.68
Market Capitalization: $151,510.11 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $0.70 |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $2.91 |
Payout Ratio: 0.00 |
| Number of Estimates in the Fiscal Year Consensus: 12.00 |
Change In Payout Ratio: 0.00 |
| Estmated Long-Term EPS Growth Rate: 13.20% |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 07/23/25 |
|
|
|
| |
